
Prof Baljean Dhillon advocated for remote practices and provided advice for implementation at the International SPECTRALIS Symposium
Prof Baljean Dhillon advocated for remote practices and provided advice for implementation at the International SPECTRALIS Symposium
Dinah Zur, MD, shares insights from her International SPECTRALIS Symposium lecture
Robyn Guymer, AM, MBBS, PhD, FRANZCO, FAHMS, presented two studies involving the EZ line at this year’s International SPECTRALIS Symposium
Ophthalmologists may be “at the forefront of a revolution in healthcare,” the nephrology professor said at this year’s International SPECTRALIS Symposium
The new technology will be crucial to imaging retinal function in the future, Prof Hüttmann predicted at the International SPECTRALIS Symposium
Prof Hogg presented a wide breadth of research at the International SPECTRALIS Symposium
A new study compared results to determine a more comprehensive understanding of the relationship between the grade of surgeon and ISBCS outcomes
ZTech-L and ZTech-P, as part of the ZTech portfolio, supports administering therapeutics in both liquid and dry powder formulations
Cabozantinib, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, has previously been associated with hepatic and dermatologic adverse effects
More than 35 lectures across seven topics, plus a keynote address, will be featured during the meeting
Research findings from the multicentre clinical study were presented at the European Society of Ophthalmology (SOE) meeting in Lisbon, Portugal
Special programming for young ophthalmologists will be hosted in the YO lounge
This year’s multi-specialty programme features the SOE Leadership Development Programme (EuLDP), the International Society of Ocular Trauma (ISOT), European University Professors of Ophthalmology (EUPO) and more
Brazilian ANVISA has granted marketing authorisation for FYB201 (Ranivisio), a biosimilar to Lucentis.
The 0.1 mg/ml atropine eye drop for paediatric myopia is licensed from Sydnexis, Inc.
Long-term benefits and vision preservation using an extended macular vision IOL
Insights from a genome-wide association study identify novel genetic loci
Laser surgery is an appropriate adjunctive therapy across the continuum of glaucoma care, as well as a safe option for patients who also have cataracts and other complicating factors
The therapy planning support tool has been trained on thousands of patient cases from more than 200 retina centres throughout Europe
The Optegra platform currently operates in the Czech Republic, the Netherlands, Poland, Slovakia and the United Kingdom
Lysine, proline and arginine levels progressively increased from non-proliferative DR to proliferative DR stages
New clinical guidance for anterior and posterior uveitis was published by a research team from the University of Bristol
Vitamins B6, B9 and B12 were found to be neuroprotective against retinal ganglion cell death
Prof Alió was commended for his work in microincisional cataract surgery and accommodative IOLs for presbyopia
The OCT platform offers deep imaging depth, rapid sweeping speed, extensive scan range, accurate results and multimodal imaging capabilities
The study found an increase in both refractive astigmatism and corneal astigmatism among a patient population of schoolchildren
Three dose level cohorts of the small interfering RNA therapeutic were evaluated in a double-blind study
Investigators sought to understand the diagnostic path, symptoms, quality of life impact and coping mechanisms of patients with GA in western Europe and the United States
The company shared results from the AAVB-081 clinical programme and AAVB-039 preclinical programme at ARVO
The investigational device, ETX-4143, was the focus of a study involving 31 patients with COSP in Australia